Editorial CommentSince the early days of transcatheter ablation procedures, various energy sources have been investigated, including direct current, microwave, ultrasound, radiofrequency, and cryothermal energy. Each alternative energy source has its associated benefits as well as complication risks. Radiofrequency energy became the standard for ablation in the early 1990s and its continued use and extensive operator experience with the technology has made radiofrequency the gold standard by which all other energies are compared. 1-4 Cryothermal energy has more recently become available for transcatheter procedures, although it has been utilized for some time in surgical techniques in the operating room. 5 The first works on transcatheter cryoablation procedures in animal models 6 were published in 1998, and were soon followed by experience in adult patients, 7 and then followed by experience in pediatric populations. 8 Many operators are now experienced with the handling characteristics of the cryoablation catheters and with the techniques of cryomapping and cryoablation. We are now familiar with the benefits and the pitfalls of cryoablation technology in clinical practice. The benefits are clear. There are numerous reports of efficacy of cryoablation for various arrhythmia substrates, with similar initial outcomes compared with radiofrequency ablation. [8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] The safety profile of cryoablation is excellent, specifically with substrates near the normal conduction of the atrioventricular node. To date, there has been no reported permanent atrioventricular block, and, in fact, one manuscript reports on the difficulty in completing atrioventricular nodal junction ablation with cryoablation. 28 Cryoablation is painless. 16 The lesions created by cryoablation are smaller, more clearly delineated, and pose a smaller thrombosis risk, compared with radiofrequency ablation. 29 The principal pitfall of cryoablation, at least at present, is the higher arrhythmia recurrence rate when compared with radiofrequency ablation. This higher recurrence rate was initially attributed to the development of operator experience with new technology. Perhaps in future reports, these recurrences will decrease. As operators have used the technology, further improvements to the cryoablation technique have been advocated and generally are aimed at creating larger cryoablation lesions. The suggested changes in technique include freeze-thaw-freeze cycles, the application of "bonus" cryoablation lesions, and the transition from a 4 mm tip to a 6 mm tip or 8 mm tip cryoablation catheter. 10,30,31 Other improvements, specifically for ablation for atrioventricular nodal reentrant tachycardia, are to have equal atrial and ventricular electrogram size on the ablation catheter 32 and to cryoablate potentially until all slow pathway conduction has been abolished. 33 Furthermore, proxy endpoints for cryoablation for atrioventricular nodal reentrant tachycardia are continuing to be d...